Russell Investments Group, Ltd. Morphic Holding, Inc. Transaction History

Russell Investments Group, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$26.12 - $34.07 $45,213 - $58,975	1,731 Added 17310.0%	1,741 $59,000
Q4 2023 Feb 05, 2024	BUY	$19.95 - $31.0 $199 - $310	10 New	10 $0
Q2 2023 Aug 10, 2023	SELL	$34.33 - $62.11 $85,825 - $155,275	-2,500 Reduced 72.15%	965 $55,000
Q1 2023 May 09, 2023	BUY	$26.01 - $48.69 $90,124 - $168,710	3,465 New	3,465 $130,000
Q2 2021 Aug 04, 2021	SELL	$45.13 - $64.99 $489,118 - $704,361	-10,838 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$29.77 - $84.85 $28,221 - $80,437	-948 Reduced 8.04%	10,838 $684,000
Q4 2020 Feb 08, 2021	BUY	$25.66 - $34.55 $302,428 - $407,206	11,786 New	11,786 $395,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.